Amneal Pharmaceuticals, Inc. Class A
(NASDAQ: AMRX)

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

12.180

+0.240 (+2.01%)
Range 11.900 - 12.215   (2.65%)
Open 12.010
Previous Close 11.940
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 1,662,904
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis